Weight gain was less pronounced with inhaled human insulin than with subcutaneous insulin (1.3 kg;
体重增加，吸入型胰岛素组比皮下注射组较少较少报道（1.3 kg；
Other adverse events were similar in both groups, except that inhaled human insulin was associated with a higher incidence of mild cough and dyspnea.
其他副作用，除吸入型胰岛素组伴发较高的轻度咳嗽和呼吸困难外，两组类似。
应用推荐